Dean Diagnostics: Subsidiary Dean Biological Antigen New Crown Detection currently has a production capacity of more than 500,000 copies/day_ Securities Times Network
Home > News > e company
Dean Diagnostics: The current production capacity of the subsidiary Dean Bioantigen new crown detection exceeds 500,000 copies/day
2022-01-30 14:21
Source: Securities Times e Company
Author: Peng Fei
Securities Times · e company
Peng Fei
2022-01-30 14:21
Securities Times e Company News, Dean Diagnostics (300244) stated that its subsidiary Dean Bioantigen New Crown Detection is the same as Jiu’an Medical’s products, and its current production capacity exceeds 500,000 copies/day; at this stage, it is still analyzing the US FDA registration matters. stage. The subsidiary Dean Bio has sold and produced more than 20 mobile shelters. Each car is equipped with 10-18 PCR equipment, with a 24-hour testing capacity of 10,000-25,000 tubes, and a one-year maintenance service.
Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.
4127542
Dean Diagnostics: The current production capacity of the subsidiary Dean Bioantigen new crown detection exceeds 500,000 copies/day
6885
e company
news
1445
Peng Fei
2022-01-30